Public preview. Funding rounds, founders, and growth signals require a free account.

Transposon Therapeutics, Inc.

Clinical-stage biopharmaceutical company developing LINE-1 reverse transcriptase inhibitors for neurodegenerative and aging-related diseases.

Series BPharmaMenlo Park, CA

Total raised

$59.1M

Last round

Convertible Note

$4.7M · Jul 2024

Stage

Series B

Status

Active

Founders & team

Co-founder, CEO

Co-founder, CTO

Head of Engineering

Head of Sales

🔒

Free account unlocks founder names, LinkedIn profiles, and prior companies.

Web traffic

Search interest

Social followers

Glassdoor rating

News mentions

Gov contracts

🔒

Free account unlocks 5 full profiles per day. Pro removes the limit.

Get notified the moment Transposon Therapeutics, Inc. files a new round, hires execs, or shows traction signals.

About this data

FlareSight surfaces funding data from SEC Form D filings within hours of submission. Browse our full startup funding database to find more recently funded companies.